>> My name is Argin Batey [phonetic] and I am a managing director with Accenture.
So I have two jobs within that industry vertical.
I lead our biotech high-growth segment, and then I also am responsible for one
of the largest relationships that the firm has with one of the clients in that business.
Yeah, so we start with that strategy, an examination of that strategy,
where they're going, and oftentimes we'll take an outside-in look at their company
through the eyes of the shareholder.
We call that "shareholder value analysis," so we'll look at what are the drivers of value
for the organization, how does that overlay with that strategy.
That oftentimes will give us insights into opportunities.
You know, where they can -- where they can do more, where they can stretch,
where can they cut, where they can grow, and that often is a great starting point,
and those dialogs and discussions happen with the C suite, so the CEO, the CFO, etc.,
and that then creates the roadmap to a host of what we would call
"transformation opportunities" for us, and some of them could be consulting oriented
where we do projects, some of them could be capability oriented where we develop things,
and Accenture's got a very broad range of services,
so we go from strategy all the way to operations.
So we actually operate parts of our clients' organizations as well,
so it's a very broad footprint, all of it in service
of improving the company's performance and, therefore,
helping them achieve their future aspirations.